Table 3.

Implementation of DOT, drug side effects, and IPTp-SP uptake.

Variables	Frequency	IPTp-SP uptake (%)			p-value
	N = 382	0-2 doses	3-4 doses	5-6 doses
Implementation of DOT					0.109
DOT observed	288	39.8	34.6	1.0
DOT not observed	87	11.8	11.0	0.0
NA	7	1.8	0.0	0.0
Prior information on drug by nurse					0.001
Information given	231	27.5	31.9	1.0
No information given	144	24.1	13.6	0.0
NA	7	1.8	0.0	0.0
Experience of drug side effects					0.133
Experienced side effects	150	19.9	19.1	0.3
Side effect not experienced	225	31.7	26.4	0.8
NA	7	1.8	0.0	0.0
Preference of DOT					0.132
Likes taking SP under DOT	250	35.3	29.3	0.8
Does not like taking SP under DOT	125	16.2	16.2	0.3
NA	7	1.8	0.0	0.0
Ever taken drugs home					0.172
Ever taken	111	15.7	13.7	0.3
Never taken	264	35.9	32.5	0.8
NA	7	1.8	0.0	0.0
Malaria infection while on IPTp-SP					0.122
Had malaria	41	6.3	4.5
Did not have malaria	337	45.3	41.1	1.0
NA	7	1.8	0.0	0.0